[Natriuretic peptides in patients with ischemic heart disease].
Yoshimura
Michihiro
M
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.
Ogawa
Hisao
H
D000789:Angina, Unstable / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000502:physiology; D015415:Biomarkers / Q000097:blood; D016207:Cytokines / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000502:physiology; D020257:Ventricular Remodeling
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D016207:Cytokines; D018836:Inflammation Mediators; D000804:Angiotensin II; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor